|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/4439 | (2006.01) |
| A61K 31/506 | (2006.01) | ||
| A61K 31/4188 | (2006.01) | ||
| A61K 31/454 | (2006.01) | ||
| A61K 31/415 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 31/12 | (2006.01) | ||
| A61P 19/02 | (2006.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61P 27/06 | (2006.01) | ||
| A61P 17/06 | (2006.01) | ||
| A01N 43/56 | (2006.01) | ||
| A61K 31/416 | (2006.01) | ||
| A61K 31/44 | (2006.01) | ||
| C07D 471/04 | (2006.01) |
| (11) | Number of the document | 2464232 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10808589.5 |
| Date of filing the European patent application | 2010-08-09 | |
| (97) | Date of publication of the European application | 2012-06-20 |
| (45) | Date of publication and mention of the grant of the patent | 2015-10-07 |
| (46) | Date of publication of the claims translation | 2016-01-25 |
| (86) | Number | PCT/US2010/044872 |
| Date | 2010-08-09 |
| (87) | Number | WO 2011/019651 |
| Date | 2011-02-17 |
| (30) | Number | Date | Country code |
| 232603 P | 2009-08-10 | US | |
| 305459 P | 2010-02-17 | US |
| (72) |
HOOD, John, US
WALLACE, David Mark, US
KC, Sunil Kumar, US
|
| (73) |
BioSplice Therapeutics, Inc.,
9360 Towne Centre Drive, San Diego, CA 92121,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Wnt signalinio kelio indazoliniai slopikliai ir jų terapiniai panaudojimai |
| INDAZOLE INHIBITORS OF THE WNT SIGNAL PATHWAY AND THERAPEUTIC USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-08-04 | 16 | 347.00 EUR |
| 2026-08-09 |